Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $22 | $8 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $28 | $11 | $8 | $3 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $73 | $73 | $40 | $40 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $73 | $73 | $40 | $40 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $101 | $84 | $48 | $43 |
| Liabilities | – | – | – | – |
| Payables | $13 | $4 | $1 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | -$1 | $0 | $0 |
| Total Curr. Liab. | $49 | $33 | $21 | $6 |
| LT Debt | $4 | $4 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $3 | $2 | $1 | $1 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $7 | $6 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $56 | $38 | $22 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$64 | -$39 | -$18 | -$5 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $45 | $46 | $26 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $101 | $84 | $48 | $43 |
| Net Debt | -$0 | $4 | -$0 | -$0 |